Cannabis’s Dark Side: High-THC Products Fueling Addiction and Health Risks

The misconception that cannabis is harmless has swung in the pendulum’s other direction as more people use it daily, but experts warn of a darker reality. While some tout its medical benefits, the truth is that high-THC products are fueling addiction and health risks.

A significant increase in THC concentrations since Woodstock (1969) has led to a new generation of potent cannabis products. The average concentration of tetrahydrocannabinol (THC), the psychoactive compound, now ranges from 15 to 30 percent. Edibles and vape pens often contain even higher levels, putting users at risk.

According to experts, high-THC products are more likely to lead to substance use disorder and overdose. Dr. Yasmin Hurd, director of the Addiction Institute at Mount Sinai Hospital, believes that Big Cannabis’s business model is similar to Big Tobacco’s, relying on addiction to drive profits.

The medical community acknowledges some benefits of cannabis but emphasizes that high-potency products are not supported by data. Studies have shown that frequent use can cause cognitive decline, memory loss, and increased risk of psychosis. Additionally, the toxicity of cannabis smoke is comparable to tobacco, posing lung damage and carcinogen risks.

Moderation is key when it comes to cannabis consumption. Users who limit their intake tend not to show significant cognitive deterioration. Experts stress the importance of informed choices, noting that “the thing that makes a poison is the dose.” However, the lack of regulation and data on cannabis use hinders our understanding of its effects, leading to self-medicating with untested products.

The Just Say No crowd was correct in some aspects; there is little evidence supporting the gateway drug hypothesis. Conversely, long-term users do experience IQ drops and reduced hippocampi volume, correlated with increased THC use. Medical applications for cannabis exist but often focus on symptom relief rather than addressing underlying conditions or illnesses.

Rescheduling cannabis to facilitate research and reduce stigma could help uncover its true benefits and drawbacks. Until then, caution is advised when consuming high-THC products and considering the potential risks of addiction and health consequences.

Source: https://washingtoncitypaper.com/article/762463/cannabis-weed-health